Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.

Saved in:
Bibliographic Details
Title: Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.
Authors: Siderowf A; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Heathers LEA; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN., Fabrizio K; Institute for Neurodegenerative Disorders, New Haven, CT., Kuhl MM; The Michael J. Fox Foundation for Parkinson's Research, New York, NY., Kopil CM; The Michael J. Fox Foundation for Parkinson's Research, New York, NY., Flagg E; Institute for Neurodegenerative Disorders, New Haven, CT., McMahon BA; Institute for Neurodegenerative Disorders, New Haven, CT., Coffey CS; Department of Biostatistics, University of Iowa, Iowa City, IW., Bright A; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN., Totten M; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN., Lemon LP; Institute for Neurodegenerative Disorders, New Haven, CT., Bryan E; Institute for Neurodegenerative Disorders, New Haven, CT., Prakash N; Institute for Neurodegenerative Disorders, New Haven, CT.; XingImaging, New Haven, CT., Pavese N; Clinical Ageing Research Unit, Newcastle University, Newcastle, UK., Bloem BR; Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Radboud University Medical Center, Nijmegen, The Netherlands., Alcalay RN; Movement Disorders Division, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Department of Neurology, Columbia University Irving Medical Center, New York, NY.; Gray Faculty of Medicine and Health Sciences and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Mirelman A; Movement Disorders Division, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Gray Faculty of Medicine and Health Sciences and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Stefanis L; First Department of Neurology, National and Kapodistrian University of Athens, Athens, Greece., Okubadejo N; Neurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria., Tolosa E; Neurology Service, Hospital Clínic of Barcelona. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, Barcelona, Spain., Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA., Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL., Chowdhury S; The Michael J. Fox Foundation for Parkinson's Research, New York, NY., Tropea TF; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.; Institute for Neurodegenerative Disorders, New Haven, CT., Marek K; Institute for Neurodegenerative Disorders, New Haven, CT., Foroud T; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN.
Corporate Authors: Parkinson's Progression Markers Initiative
Source: Annals of neurology [Ann Neurol] 2026 May 10. Date of Electronic Publication: 2026 May 10.
Publication Type: Editorial
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1531-8249
DOI:10.1002/ana.78239